Common examples include: Direct Oral Anticoagulants (DOACs): Eliquis (apixaban), Xarelto (rivaroxaban), and Pradaxa (dabigatran)
Dont forget to check out our Facebook and Instagram pages too, where you can find regular inspiration, news, and announcements about other incredible treatments we offer.
By combining genetic insight with biomarker data and clinical assessment, patients and providers can support a more informed conversation about optimal semaglutide dosing strategy
Pairing genetic insight with your symptom history, dosing duration, and metabolic markers can support a more personalized conversation with your provider about optimal discontinuation timing and whether a different compounded GLP-1 approachsuch as microdose protocols or dual-compound therapiesmight align better with your body's characteristics
These drugs offer substantial potential health benefits, but the combination of intense demand, new uses, and high prices for these treatments is likely to place tremendous pressure on Medicare spending, Part D plan costs, and premiums for Part D coverage.
